Noah Clauser insider trades

Open-market stock purchases and sales by Noah Clauser, Chief Financial Officer at Astria Therapeutics, Inc, from SEC Form 4 filings since Feb 12, 2020.

Recent trades

DateStockTradeValue
Jan 23, 2026ATXS Astria Therapeutics, IncSold (not open market)$358K
Jan 23, 2026ATXS Astria Therapeutics, IncSold (not open market)$1.7M

Companies traded

  • ATXS Astria Therapeutics, Inc: other filings, last Jan 23, 2026
  • CATB Catabasis Pharmaceuticals Inc: other filings, last Jun 2, 2021

Get free alerts when Noah Clauser files a new trade →